Waltz Health, Fresenius Kabi partner for direct-to-payer biosimilar program
Digital health company Waltz Health is teaming up with drugmaker Fresenius Kabi to support direct-to-employer efforts for key biosimilar medications.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.